Primecap Management CO Immunocore Holdings PLC Transaction History
Primecap Management CO
- $122 Billion
- Q2 2025
A detailed history of Primecap Management CO transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Primecap Management CO holds 3,771,474 shares of IMCR stock, worth $120 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,771,474
Previous 2,678,650
40.8%
Holding current value
$120 Million
Previous $79.5 Million
48.91%
% of portfolio
0.1%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding IMCR
# of Institutions
144Shares Held
44.9MCall Options Held
297KPut Options Held
1.11M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$225 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$155 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$134 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$77.8 Million1.74% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74 Million0.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.4B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...